Condition: Spasticity · Sponsor: Ipsen
The purpose of the study is to assess the safety and efficacy of increasing doses of Corabotase (also known as IPN10200) with the aim to evaluate the Pharmacodynamics (PD) profile of Corabotase and to establish the total Corabotase doses(s) that offer the best efficacy/safety profile when used for the treatment of Adult upper limb (AUL) spasticity.
This description comes directly from the study's public registry record.
Ipsen Recruitment Enquiries · see email · clinical.trials@ipsen.com
Always discuss trial participation with your own doctor first.
| Rancho Los Amigos National Rehab | Downey, California, United States | Recruiting |
| Kansas Institute of Research | Overland Park, Kansas, United States | Recruiting |
| Quest Research Institute | Farmington Hills, Michigan, United States | Terminated |
| Einstein Physical Medicine and Rehabilitation at Elkins Park | Elkins Park, Pennsylvania, United States | Recruiting |
| The University of Texas Southwestern Medical Center | Dallas, Texas, United States | Recruiting |
| Medical University Innsbruck, Department of Neurology | Innsbruck, Austria | Recruiting |
| Kepler University Hospital GmbH, Department of Neurology and Psychiatry | Linz, Austria | Recruiting |
| Brothers of Charity Hospital Linz, Department of Neurology I | Linz, Austria | Recruiting |
| Medical University Vienna, Department of Neurology | Vienna, Austria | Withdrawn |
| Multiprofile Hospital for Active Treatment "Heart and Brain" | Pleven, Bulgaria | Withdrawn |
| Medical Center "Rusemed" EOOD | Rousse, Bulgaria | Recruiting |
| Multiprofile Hospital for Active Treatment of Neurology and Psychiatry "Sveti Naum", Sofia, Neurological Diseases Clinic for Neurodegenerative and Peripheral Neurological Diseases | Sofia, Bulgaria | Recruiting |
+ 69 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04752774